Microarray analysis of interferon-regulated genes in SLE

Autoimmunity

Volumn 36, Issue 8, 2003, Pages 481-490

  Crow, Mary K ^a   Kirou, Kyriakos A ^a   Wohlgemuth, Jay ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Expression Diagnostics Inc   (United States)

Author keywords

Gene expression; Interferon induced genes; Interferons; Microarray; Systemic lupus erythematosus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE 1; 2',5' OLIGOADENYLATE SYNTHETASE 2; 2',5' OLIGOADENYLATE SYNTHETASE LIKE; 4 AMINOBUTYRIC ACID B RECEPTOR 1; ALPHA INTERFERON; BETA INTERFERON; CD38 ANTIGEN; CORTICOSTEROID; CYTOKINE; G PROTEIN COUPLED RECEPTOR 105; GALACTOSIDE BINDING LECTIN 9; GAMMA INTERFERON; HEAT SHOCK PROTEIN 1A; INTERFERON; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 7; INTERFERON STIMULATED PROTEIN; LYMPHOCYTE ANTIGEN 6 COMPLEX; LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN 3; METALLOTHIONEIN 1A; METALLOTHIONEIN 1B; METALLOTHIONEIN III; PERFORIN 1; PROTEIN; PROTEIN KINASE D2; RAS ASSOCIATION DOMAIN CONTAINING PROTEIN; SCRAMBLASE 1; STAT2 PROTEIN; SYNAPTOBREVIN 5; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD CELL; CANCER; DNA MICROARRAY; DRUG EFFECT; DRUG MEGADOSE; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNE SYSTEM; MONONUCLEAR CELL; MOUSE; PATHOGENESIS; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0344665750     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930310001625952     Document Type: Review

References (55)

1. Hooks, J.J., Moutsopoulos, H.M., Geis, S.A., Stahl, N.I., Decker, J.L. and Notkins, A.L. (1979) "Immune interferon in the circulation of patients with autoimmune disease", N. Engl. J. Med. 301, 5-8.
2. Hooks, J.J., Jordan, G.W., Cupps, T., Moutsopoulos, H.M., Fauci, A.S. and Notkins, A.L. (1982) "Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis", Arthritis Rheum. 25, 396-400.
3. Shi, S.N., Feng, S.F., Wen, Y.M., He, L.F. and Huang, Y.X. (1987) "Serum interferon in systemic lupus erythematosus", Br. J. Dermatol. 117, 155-159.
4. Preble, O.T., Black, R.J., Friedman, R.M., Klippel, J.H. and Vilcek, J. (1982) "Systemic lupus erythematosus: Presence in human serum of an unusual acid-labile leukocyte interferon", Science 216, 429-431.
5. Yee, A.M., Yip, Y.K., Fischer, H.D. and Buyon, J.P. (1990) "Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: Its association with disease activity and its independence from circulating alpha-interferon", Arthritis Rheum. 33, 563-568.
6. Boumpas, D.T., Hook, J.J., Popovic, M., Tsokos, G.C. and Mann, D.L. (1985) "Human T-cell leukemia/lymphoma virus I and/or Epstein-Barr virus-infected B-cell lines spontaneously produce acid-labile alpha-interferon", J. Clin. Immunol. 5, 340-344.
7. Capobianchi, M.R., Mattana, P., Mercuri, F., Conciatori, G., Ameglio, F., Ankel, H. and Dianzani, F. (1992) "Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells", J. Interferon Res. 12, 431-438.
8. Rich, S.A. (1981) "Human lupus inclusions and interferon", Science 213, 772-775.
9. Ronnblom, L.E., Alm, G.V. and Oberg, K.E. (1990) "Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour", J. Intern. Med. 227, 207-210.
10. Wandl, U., Nagel-Hiemke, M., May, D., Kreuzfelder, E., Kloke, O., Kranzhoff, M., Seeber, S. and Niederle, N. (1992) "Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders", Clin. Immunol. Immunopathol. 65, 70-74.
11. Zhang, Z.X., Milich, D.R., Peterson, D.L., Birkett, A., Schvarcz, R., Weiland, O. and Sallberg, M. (1997) "Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy", J. Infect. Dis. 175, 1294-1301.
12. Schilling, P.J., Kurzrock, R., Kantarjian, H., Gutterman, J.U. and Talpaz, M. (1991) "Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia", Cancer 68, 1536-1537.
13. Pittau, E., Bogliolo, A., Tinti, A., Mela, Q., Ibba, G., Salis, G. and Perpignano, G. (1997) "Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C", Clin. Exp. Rheumatol. 15, 415-419.
14. Gota, C. and Calabrese, L. (2003) "Induction of clinical autoimmune disease by therapeutic interferon-alpha", Autoimmunity 36.
15. Peng, S.L., Moslehi, J. and Craft, J. (1997) "Roles of interferon-gamma and interleukin-4 in murine lupus", J. Clin. Investig. 99, 1936-1946.
16. Lawson, B.R., Prud'homme, G.J., Chang, Y., Gardner, H.A., Kuan, J., Kono, D.H. and Theofilopoulos, A.N. (2000) "Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc", J. Clin. Investig. 106, 207-215.
17. Santiago-Raber, M.L., Baccala, R., Haraldsson, K.M., Choubey, D., Stewart, T.A., Kono, D.H. and Theofilopoulos, A.N. (2003) "Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice", J. Exp. Med. 197, 777-788.
18. Braun, D., Gerales, P. and Demengeot, J. (2003) "Type I interferon controls the onset and severity of autoimmune manifestations in 1pr mice", J. Autoimmun. 20, 15-25.
19. Kono, D.H., Baccala, R. and Theofilopoulos, A.N. (2003) "Inhibition of lupus by genetic alteration of the interferon-α/β receptor", Autoimmunity 36.
20. Rönnblom, L., Eloranta, M.-L. and Alm, G.V. (2003) "Role of natural interferon-α producing cells (plasmacytoid dendritic cells) in autoimmunity", Autoimmunity 36.
21. Vallin, H., Blomberg, S., Alm, G.V., Cederblad, B. and Ronnblom, L. (1999) "Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-α) production acting on leukocytes resembling immature dendritic cells", Clin. Exp. Immunol. 115, 196-202.
22. Vallin, H., Peters, A., Alm, G.V. and Ronnblom, L. (1999) "Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus", J. Immunol. 163, 6303-6313.
23. Bave, U., Alm, G.V. and Ronnblom, L. (2000) "The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer", J. Immunol. 165, 3519-3526.
24. Bave, U., Vallin, H., Alm, G.V. and Ronnblom, L. (2001) "Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines", J. Autoimmun. 17, 71-80.
25. Magnusson, M., Magnusson, S., Vallin, H., Ronnblom, L. and Alm, G.V. (2001) "Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxy-nucleotide", Scand. J. Immunol. 54, 543-550.
26. Blanco, P., Palucka, A.K., Gill, M., Pascual, V. and Banchereau, J. (2001) "Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus", Science 294, 1540-1543.
27. Radvanyi, L.G., Banerjee, A., Weir, M. and Messner, H. (1999) "Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 50, 499-509.
28. Luft, T., Pang, K.C., Thomas, E., Herzog, P., Hart, D.N., Trapani, J. and Cebaon, J. (1998) "Type I IFNs enhance the terminal differentiation of dendritic cells", J. Immunol. 161, 1947-1953.
29. Crow, M.K. (2003) "Interferon-alpha: A new target for therapy in SLE?", Arthritis Rheum. 48, 2396-2401.
30. Crow, M.K., George, S., Paget, S.A., Ly, N., Woodward, R., Fry, K., Chan, A., Prentice, J. and Wohlgemuth, J. (2002) "Expression of an interferon-alpha gene program in SLE", Arthritis Rheum. 46, S281.
31. Baechler, E.C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., Ortmann, W.A., Espe, K.J., Shark, K.B., Grande, W.J., Hughes, K.M., Kapur, V., Gregersen, P.K. and Behrens, T.W. (2003) "Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus", Proc. Natl Acad. Sci. USA 100, 2610-2615.
32. Bennett, L., Palucka, A.K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual, V. (2003) "Interferon and granulopoiesis signatures in systemic lupus erythematosus blood", J. Exp. Med. 197, 711-723.
33. Han, G.M., Chen, S.L., Shen, N., Ye, S., Bao, C.D. and Gu, Y.Y. (2003) "Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray", Genes. Immun. 4, 177-186.
34. Brown, P.O. and Botstein, D. (1999) "Exploring the new world of the genome with DNA microarray", Nat. Genet. 21, 33-37.
35. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenberger, D.D., Armitage, J.O., Warnke, R. and Staudt, L.M. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature 403, 503-511.
36. Crow, M.K. and Wohlgemuth, J. (2003) "Microarray analysis of gene expression in lupus", Arthritis Res. Ther. 5, 279-287.
37. Biron, C.A. (2001) "Interferons alpha and beta as immune regulators - A new look", Immunity 14, 661-664.
38. Der, S.D., Zhou, A., Williams, B.R. and Silverman, R.H. (1998) "Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays", Proc. Natl Acad. Sci. USA 95, 15623-15628.
39. Barnes, B.J., Moore, P.A. and Pitha, P.M. (2001) "Virus-specific activation of a novel interferon regulatory factor 5, results in the induction of distinct interferon alpha genes", J. Biol. Chem. 276, 23382-23390.
40. Su, A.I., Pezacki, J.P., Wodicka, L., Brideau, A.D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R.H., Schultz, P.G. and Chisari, F.V. (2002) "Genomic analysis of the host response to hepatitis C virus infection", Proc. Natl Acad. Sci. USA 99, 15669-15674.
41. Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L. and Iggo, R. (2003) "Induction of an interferon response by RNAi vectors in mammalian cells", Nat. Genet. 34, 263-264.
42. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) "Significance analysis of microarrays applied to the ionizing radiation response", Proc. Natl Acad. Sci. USA 98, 5116-5121.
43. Rus, V., Atamas, S.P., Shustova, V., Luzina, I.G., Selaru, F., Magder, L.S. and Via, C.S. (2002) "Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array", Clin. Immunol. 102, 283-290.
44. Maas, K., Chan, S., Parker, J., Slater, A., Moore, J., Olsen, N. and Aune, T.M. (2002) "Cutting edge: Molecular portrait of human autoimmune disease", J. Immunol. 169, 5-9.
45. Tezak, Z., Hoffman, E.P., Lutz, J.L., Fedczyna, T.O., Stephan, D., Bremer, E.G., Krasnoselska-Riz, I., Kumar, A. and Pachman, L.M. (2002) "Gene expression profiling in DQA1*0501* + children with untreated dermatomyositis: A novel model of pathogenesis", J. Immunol. 168, 4154-4163.
46. Wandinger, K.-P., Sturzebecher, C.-S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L.M., McFarland, H.F. and Martin, R. (2001) "Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes", Ann. Neurol. 50, 349-357.
47. Carmody, R.J., Hilliard, B., Maguschak, K., Chodosh, L.A. and Chen, Y.H. (2002) "Genomic scale profiling of autoimmune inflammation in the central nervous system: The nervous response to inflammation", J. Neuroimmunol. 133, 95-107.
48. Mycko, M.P., Papoian, R., Boschert, U., Raine, C.S. and Selmaj, K.W. (2003) "cDNA microarray analysis in multiple sclerosis lesions: Detection of genes associated with disease activity", Brain 126, 1048-1057.
49. Whitney, A.R., Diehn, M., Popper, S.J., Alizadeh, A.A., Boldrick, J.C., Relman, D.A. and Brown, P.O. (2003) "Individuality and variation in gene expression patterns in human blood", Proc. Natl Acad. Sci. USA 100, 1896-1901.
50. Svensson, H., Johannisson, A., Nikkila, T., Alm, G.V. and Cederblad, B. (1996) "The cell surface phenotype of human natural interferon-α producing cells as determined by flow cytometry", Scand. J. Immunol. 44, 164-172.
51. Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., Ho, S., Antonenko, S. and Liu, Y.J. (1999) "The nature of the principal type I interferon-producing cells in human blood", Science 284, 1835-1837.
52. Ronnblom, L. and Alm, G.V. (2001) "A pivotal role for the natural interferon α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus", J. Exp. Med. 194, 59-63.
53. Brinkmann, V., Geiger, T., Alkan, S. and Heusser, C.H. (1993) "Interferon alpha increases the frequency of interferon gamma-producing human CD4 + T cells", J. Exp. Med. 178, 1655-1663.
54. + T cells and monocytes", Blood 87, 4731-4736.
55. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D.F. (2001) "Type I interferons potently enhance immunity and can promote isotype switching by stimulating dendritic cells in vivo", Immunity 14, 461-470.